myeloproliferative neoplasms
Conditions
Interventions
Experimental group:Longchaijiangxue granules+Yigong Powder+Basic treatment
Control group:Yigong Powder+Basic treatment
Sponsors
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Meets WHO diagnostic criteria for PV, ET. (2) PLT < 1000 x 109/L and HCT < 60%. (3) Age above 18 years (including 18 years) and below 80 years (including 80 years), with no restriction on gender. (4) Voluntarily subjected to the trial and signed an informed consent form. (5) Not participating in other clinical studies.
Exclusion criteria
Exclusion criteria: (1) Cases that met the inclusion criteria but were not treated after inclusion. (2) Patients with no record of testing. (3) Those using prohibited drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gene detection;Routine Blood Test(WBC\RBC\PLT\HGB etc.);Coagulation items; | — |
Countries
China
Contacts
Public ContactHu-Xiaomei
Outcome results
None listed